Answers are grounded in this paper and cite their sources.
This cohort study compares time trends in the use of neoadjuvant chemotherapy and survival rates among women with advanced-stage epithelial ovarian cancer.
No takes yet. Share an insight, caveat, or question.
Knisely et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: